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This article presents processed data from an analysis of cross-
sectional data from Cycle 1 of the Canadian Health Measures Sur-
vey (CHMS) to examine the potential association between urinary
concentrations of BPA and phthalate metabolites and child learning
and behavioral problems, considering important covariates such as
gender, blood lead and environmental tobacco smoke (ETS). These
processed data are related to the research on a subset of the children
(Arbuckle et al., 2016) [1]. The Strengths and Difﬁculties Ques-
tionnaire (SDQ) outcomes of interest were emotional symptoms,
hyperactivity/inattention, and a total difﬁculties SDQ score, with
borderline and abnormal scores grouped together and compared
with children with normal scores. Other outcomes studied included
reported learning disability, ADD/ADHD (attention deﬁcit disorder/
attention deﬁcit hyperactivity disorder) and use of psychotropic
medications to treat behavioral disorders in the past month. Data are
presented for all children 6–19 years of age combined.
Weighted simple logistic regression estimates for important
covariates of each of the outcomes from CHMS Cycle 1 children are
reported. Odds ratios based on weighted multiple logistic regression
estimates for urinary BPA and phthalate metabolites (including











T.E. Arbuckle et al. / Data in Brief 8 (2016) 784–802 785reported outcomes ADD/ADHD, learning disability and psychotropic
medications, as well as the SDQ outcomes emotional symptoms,
hyperactivity/inattention and total difﬁculties.
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Value of the data
 Cross-sectional analysis of associations between child levels of BPA, phthalates and lead with
indicators of adverse child behavior, controlling for wide set of covariates.
 Generates exploratory data useful for examination in prospective cohort studies.
 Could be compared with similar data from US NHANES for further insight.1. Data
Tables of results of simple weighted regression analysis of important covariates and weighted
multiple logistic regression analysis for chemicals examined. Child behavioral outcomes considered
were reported learning disability, ADD/ADHD and taking psychotropic medications, as well as
Strengths and Difﬁculties Questionnaire scores for hyperactivity/inattention, emotional symptoms
and total difﬁculties.2. Experimental design, materials and methods
The Canadian Health Measures Survey (CHMS) was designed to collect key information on
the health of Canadians using direct physical measurements, collection of blood and urine and
household and clinic interviews [2,3]. The target population for Cycle 1 were individuals
between 6 and 79 years of age living in privately occupied dwellings, representing 97% of
Canadians. This dataset was restricted to children and adolescents 6–19 years of age (n¼2097).
Information on child behavior, demographic, socioeconomic and lifestyle factors was collected
by a questionnaire administered to the parent or guardian of children 6–11 years of age or
directly to the child 12 years and older.
Blood was analysed for lead, while urine was analysed for BPA and phthalate metabolites. Crea-
tinine was measured to adjust for urine dilution differences between spot urine samples. Chemical lab
measures below the limit of detection were imputed as half the limit of detection.
For children 6–19 years of age, outcomes examined were reports of self-, or in the case of children
6–11 years, parent-reported learning disability (any, ADD or ADHD) and whether any medications
used to treat behavioral disorders were taken in the past month. Respondents reported medications
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eng.php) which were coded to Anatomical Therapeutic Chemical (ATC) codes (http://www.whocc.no/
atc_ddd_index/). One of the co-authors (KB), a clinical child psychiatrist, provided a table of medi-
cations potentially used for treating behavioral disorders in children (see Supplemental Material,
Table S1 [1]).
For children 6–17 years of age, borderline and abnormal scores from the Strengths and Difﬁculties
Questionnaire (SDQ) (www.sdqinfo.com) were grouped together and compared with children with
normal scores for the outcomes emotional symptoms, hyperactivity/inattention, and the total difﬁ-
culties scores.
Initially, for each outcome of interest, weighted univariate models were considered for each
contaminant. Subsequently, potential risk factors were evaluated. Covariates identiﬁed through
reviews of the literature included child's age, body mass index, number of hours slept per night,
gender, highest level of household education (secondary school or less vs. at least some post-
secondary studies), income adequacy (low/lower middle vs. upper middle/higher income), whether
the child fasted prior to specimen collection, and ETS exposure in the home. For children 6–11 years
of age only, additional covariates were available and considered: prenatal smoking, birth any time
prior to due date, admission to a special neonatal unit or an intensive care unit prior to leaving
hospital, and breast feeding (less than 3 months vs. three months or longer), as well as number of
days in a neonatal unit, birth weight, and mother's age at birth.
Since the CHMS employed a complex, multistage survey design, survey weights were used in
statistical modeling to account for the unequal probabilities of selection. Due to the complex sampling
scheme of the CHMS Cycle 1 survey, direct calculation of standard errors and conﬁdence intervals
were not possible. To that end, Statistics Canada [3] provided bootstrap weights in order to calculate
standard errors, conﬁdence intervals and coefﬁcients of variation for each estimate using the boot-
strap method.
Weighted simple logistic regression modelling was done for each of the identiﬁed covariates and
the outcomes (Tables A1–A7). Weighted multiple logistic regression models were then run con-
sidering the environmental contaminants and other important covariates identiﬁed in the simple
regressions (Tables B1–B6). For urinary chemicals, creatinine concentration was included in all the
multiple regression models as a separate independent variable [4].
In order to determine which of the available variables resulted in the best ﬁt, a stepwise
procedure was implemented. The natural-log of the contaminant concentrations was used since
the contaminants were lognormally distributed based on the Anderson–Darling test. However
since the complex survey design limited the number of degrees of freedom to 11, a stepwise
selection method was used to determine which covariates were most signiﬁcant to improve the
model ﬁt. The contaminant and creatinine concentrations were retained in the model, and then
other covariates were sequentially added to the model based on the smallest p-value (i.e. the
most signiﬁcant variables). This approach facilitated the evaluation of demographic variables
one-at-a-time with respect to their p-value, conditional on other variables already in the model.
This approach also served to examine the effect of multicollinearity, which could inﬂate stan-
dard errors and provide misleading results. For some models, after examining the main effects,
sufﬁcient degrees of freedom were available to evaluate an interaction term between highly
signiﬁcant covariates. Furthermore, to compare models, the model with signiﬁcant terms and
with the lowest value of the Akaike Information Criterion (AIC) was selected. Goodness of ﬁt was
assessed using the Hosmer–Lemeshow test. Odds ratios were calculated from weighted multiple
logistic regression models for a 1-unit increase in the log of the contaminant concentration
(Tables C1 and C2).
The software package SAS (Statistical Analysis System) Enterprise Guide 4.2 was used for statistical
analysis. For regression modeling, the software programs BOOTVAR and SUDAAN were used along
with the bootstrap weights, in order to correctly calculate such estimates. Finally, for all statistical
analysis performed, an inference was deemed signiﬁcant at α¼5% unless otherwise indicated.
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See Tables A1–A7Table A2
Weighted simple logistic regression estimates for covariates from CHMS Cycle 1 with outcome reported ADHD (6–19 years
of age).
Outcome: ADHD
Factor (reference category) n Estimate Standard error P-value Odds ratio (OR) 95% CI for odds ratio
Child's age 2087 0.000 0.05 0.95 1.00 0.90 1.1
BMI – measured 2081 0.05 0.04 0.16 0.95 0.87 1.03
Gender (males) 2087 1.31 0.48 0.02 3.69 1.27 10.71
Education (secondary school or less) 2031 0.11 0.66 0.87 0.90 0.20 3.96
Income (low/lower middle) 1927 0.96 0.45 0.06 2.62 0.96 7.13
Prenatal smoking 1038 1.22 0.35 0.006 3.39 1.55 7.40
Born any time before due date 1047 0.62 0.39 0.140 1.87 0.79 4.39
Special neonatal unit care 1039 NR NR NR NR NR NR
No. of days in neonatal unit 1066 NR NR NR NR NR NR
Hours of sleep per night 2087 0.03 0.13 0.83 0.97 0.73 1.29
Birth weight 1039 0.00 0.00 0.78 1.00 1.00 1.00
Breast feeding (3 months or longer) 1037 0.48 0.79 0.55 0.62 0.11 3.48
Mother's age at birth 1065 0.11 0.07 0.14 0.90 0.77 1.04
Anyone smoking at home (Yes) 2082 0.67 0.5 0.21 1.95 0.65 5.83
Fasted (yes) 2087 0.38 0.33 0.26 1.47 0.72 3.00
NR – Not reported due to unacceptable quality.
Table A1
Weighted simple logistic regression estimates for covariates from CHMS Cycle 1 with outcome reported ADD (6–19 years
of age).
Outcome: ADD
Factor (reference category) n Estimate Standard error P-value Odds ratio (OR) 95% CI for Odds
ratio
Child's age 2087 0.14 0.06 0.05 1.15 1.00 1.33
BMI – measured 2081 0.00 0.04 0.97 1.00 0.91 1.09
Gender (males) 2087 1.04 0.58 0.10 2.83 0.79 10.06
Education (secondary school or less) 2031 0.73 0.52 0.18 2.07 0.67 6.45
Income (low/lower middle) 1927 1.04 0.48 0.05 2.83 0.99 8.09
Prenatal smoking (yes) 1038 0.27 0.71 0.71 1.31 0.24 7.10
Born any time before due date (yes) 1047 0.95 0.61 0.18 2.6 0.54 12.39
Special neonatal unit care (yes) 1047 1.24 0.4 0.01 3.47 1.40 8.57
No. of days in neonatal unit 1066 0.01 0.11 0.9 1.01 0.8 1.29
Hours of sleep per night 2087 0.17 0.16 0.31 0.84 0.59 1.21
Birth weight 1039 0.00 0.00 0.21 1.00 1.00 1.00
Breast feeding (3 months or longer) 1037 0.77 0.67 0.28 0.46 0.10 2.03
Mother's age at birth 1065 0.03 0.06 0.6 0.97 0.84 1.11
Anyone smoking at home (yes) 2082 1.48 0.49 0.01 4.38 1.49 12.88
Fasted (yes) 2087 0.14 0.47 0.77 0.87 0.30 2.46
Table A4
Weighted simple logistic regression estimates for covariates from CHMS Cycle 1 with outcome reported psychotropic medi-
cines taken in past month (6 – 19 years of age).
Outcome: Medicine taken
Factor (reference category) n Estimate Standard error P-value Odds ratio (OR) 95% CI for odds
ratio
Child's age 2096 0.00 0.03 0.99 1.00 0.94 1.06
BMI – measured 2090 0.05 0.04 0.25 1.05 0.96 1.15
Gender (males) 2096 0.79 0.26 0.01 2.21 1.25 3.93
Education (secondary school or less) 2041 0.67 0.59 0.28 1.95 0.53 7.14
Income (low/lower middle) 1936 0.30 0.57 0.61 1.35 0.39 4.70
Prenatal smoking (yes) 1043 0.87 0.6 0.17 2.40 0.64 9.01
Born any time before due date (yes) 1053 0.76 0.21 0.004 2.14 1.34 3.42
Special neonatal unit care (yes) 1073 0.07 0.49 0.89 0.93 0.32 2.77
No. of days in neonatal unit 1072 0.00 0.05 0.94 1 0.89 1.11
Hours of sleep per night 2096 0.2 0.06 0.008 0.82 0.72 0.94
Birth weight 1045 0.00 0.00 0.03 1.00 1.00 1.00
Breast feeding (3 months or longer) 1043 0.98 0.59 0.13 0.38 0.10 1.38
Mother's age at birth 1071 0.04 0.05 0.46 0.96 0.86 1.07
Anyone smoking at home (yes) 2091 0.67 0.61 0.30 1.95 0.51 7.55
Fasted (yes) 2096 0.95 0.21 0.01 1.87 1.17 2.98
Table A3
Weighted simple logistic regression estimates for covariates from CHMS Cycle 1 with outcome reported learning disability (6–
19 years of age).
Outcome: Learning disability
Factor (reference category) n Estimate Standard error P-value Odds ratio (OR) 95% CI for odds ratio
Child's age 2094 0.04 0.03 0.33 1.04 0.96 1.12
BMI – measured 2088 0.01 0.02 0.6 1.01 0.97 1.05
Gender (males) 2094 0.85 0.31 0.02 2.34 1.19 4.60
Education (secondary school or less) 2038 0.26 0.26 0.33 1.30 0.74 2.3
Income (low/lower middle) 1934 0.92 0.24 0.003 2.50 1.47 4.27
Prenatal smoking (yes) 1043 0.71 0.35 0.07 2.04 0.94 4.42
Born any time before due date (yes) 1052 0.28 0.26 0.30 1.32 0.75 2.35
Special neonatal unit care (yes) 1072 0.82 0.35 0.04 2.27 1.06 4.86
No. of days in neonatal unit 1071 0.01 0.02 0.66 1.01 0.97 1.05
Hours of sleep per night 2094 0.1 0.1 0.35 0.91 0.73 1.13
Birth weight 1044 0 0 0.86 1.00 1.00 1.00
Breast feeding (3 months or longer) 1042 0.25 0.33 0.46 0.78 0.38 1.6
Mother's age at birth 1070 0.06 0.04 0.13 0.94 0.86 1.02
Anyone smoking at home (yes) 2089 0.84 0.21 0.002 2.32 1.48 3.64
Fasted (yes) 2094 0.1 0.20 0.63 1.10 0.71 1.72
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Table A5
Weighted simple logistic regression estimates for covariates from CHMS Cycle 1 with outcome SDQ emotional symptoms (ages
6–17 years).
Outcome: SDQ emotional symptoms
Factor (reference category) n Estimate Standard error P-value Odds ratio (OR) 95% CI for odds
ratio
Child's age 1717 0.02 0.02 0.48 1.02 0.97 1.07
BMI – measured 1715 0.06 0.03 0.05 1.06 1.00 1.13
Gender (males) 1717 0.44 0.17 0.03 0.65 0.44 0.95
Education (Secondary school or less) 1676 0.65 0.29 0.04 1.92 1.03 3.61
Income (low/lower middle) 1649 0.34 0.26 0.22 1.40 0.79 2.49
Prenatal smoking (yes) 1045 0.34 0.51 0.53 1.40 0.45 4.34
Born any time before due date (yes) 1054 0.47 0.23 0.07 1.60 0.96 2.67
Special neonatal unit care (yes) 1074 0.47 0.37 0.23 1.60 0.71 3.57
No. of days in neonatal unit 1073 0.02 0.04 0.98 1.00 0.96 1.04
Hours of sleep per night 1717 0.2 0.07 0.02 0.82 0.70 0.95
Birth weight 1046 0 0 0.12 1.00 1.00 1.00
Breast feeding (3 months or longer) 1044 0.29 0.23 0.23 0.75 0.46 1.23
Mother's age at birth 1072 0 0.01 0.91 1.00 0.97 1.03
Anyone smoking at home (yes) 1713 0.24 0.26 0.38 1.27 0.71 2.27
Fasted (yes) 1717 0.5 0.18 0.02 1.65 1.10 2.47
Table A6
Weighted simple logistic regression estimates for covariates from CHMS Cycle 1 with outcome SDQ hyperactivity/inattention
(ages 6–17 years).
Outcome: SDQ hyperactivity/inattention
Factor (reference category) n Estimate Standard error P-value Odds ratio (OR) 95% CI for odds
ratio
Child's age 1717 0.05 0.04 0.15 0.95 0.88 1.02
BMI – measured 1715 0.00 0.02 0.84 1.00 0.96 1.04
Gender (males) 1717 0.51 0.14 0.004 1.66 1.22 2.24
Education (secondary school or less) 1676 0.52 0.26 0.08 1.68 0.94 2.99
Income (low/lower middle) 1649 0.52 0.20 0.02 1.68 1.09 2.58
Prenatal smoking (yes) 1045 0.9 0.28 0.009 2.47 1.32 4.61
Born any time before due date (yes) 1054 0.07 0.14 0.63 0.93 0.69 1.27
Special neonatal unit care (yes) 1074 0.1 0.36 0.79 0.90 0.41 2.02
No. of days in neonatal unit 1073 0.02 0.95 0.95 1.00 0.96 1.04
Hours of sleep per night 1717 0.04 0.08 0.68 0.97 0.81 1.16
Birth weight 1046 0 0 0.88 1.00 1.00 1.00
Breast feeding (3 months or longer) 1044 0.41 0.18 0.04 0.66 0.45 0.98
Mother's age at birth 1072 0.02 0.02 0.29 0.98 0.94 1.02
Anyone smoking at home (yes) 1713 0.78 0.31 0.03 2.18 1.11 4.31
Fasted (yes) 1717 0.02 0.22 0.92 1.02 0.63 1.67
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Table A7
Weighted simple logistic regression estimates for covariates from CHMS Cycle 1 with outcome SDQ total difﬁculties (ages 6–17
years).
Outcome: SDQ total difﬁculties
Factor (reference category) n Estimate Standard error P-value Odds ratio (OR) 95% CI for odds ratio
Child's age 1717 0.05 0.05 0.31 0.95 0.86 1.06
BMI – measured 1715 0.04 0.03 0.30 1.04 0.97 1.11
Gender (males) 1717 0.26 0.24 0.29 1.30 0.77 2.19
Education (secondary school or less) 1676 0.42 0.54 0.45 1.52 0.46 5.02
Income (low/lower middle) 1649 0.69 0.30 0.04 1.99 1.02 3.89
Prenatal smoking (yes) 1045 1.15 0.43 0.02 3.17 1.24 8.09
Born any time before due date (yes) 1054 0.32 0.20 0.13 1.38 0.90 2.13
Special neonatal unit care (yes) 1074 0.35 0.24 0.18 1.42 0.83 2.42
No. of days in neonatal unit 1073 0.00 0.01 0.85 1.00 0.98 1.02
Hours of sleep per night 1717 0.09 0.12 0.48 0.92 0.70 1.20
Birth weight 1046 0.00 0.00 0.65 1.00 1.00 1.00
Breast feeding (3 months or longer) 1044 0.45 0.17 0.02 0.64 0.43 0.93
Mother's age at birth 1072 0.03 0.03 0.35 0.97 0.91 1.04
Anyone smoking at home (yes) 1713 0.77 0.33 0.04 2.16 1.04 4.50
Fasted (yes) 1717 0.37 0.28 0.21 1.45 0.78 2.69
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See Tables B1–B6
Table B1
Weighted multiple logistic regression estimates from CHMS Cycle 1 with reported ADD/ADHD (6–19 years of age).




BPA Intercept 2.96 0.72 0.0018
ln(creatinine) 0.28 0.18 0.1626 0.76 0.51 1.14
ln(BPA) 0.26 0.18 0.6089 1.29 0.86 1.94
Smoking at home
(yes)
0.84 0.34 0.0312 2.32 1.10 4.90
Child's age 0.05 0.05 0.3131
Income (low/low-
middle)
0.67 0.31 0.0533 1.95 0.99 3.83
Gender (males) 0.17 0.63 0.7911 Gender: males vs. femalesa 3.06 1.67 5.61
BMI 0.10 0.03 0.0152 0.91 0.84 0.98
ln(lead) 0.83 0.26 0.0087 2.28 1.29 4.04
Gender*child's age 0.10 0.05 0.0593 Age: males 1.16 1.06 1.27
Age: females 1.05 0.96 1.15
Blood
lead
Intercept 4.13 0.40 o0.0001
ln(lead) 0.87 0.27 0.0080 2.39 1.32 4.32
Smoking at home
(yes)
0.93 0.35 0.0215 2.54 1.18 5.46
Gender (males) 1.08 0.32 0.0064 2.93 1.45 5.94
Income (low/low-
middle)
0.76 0.38 0.0674 2.15 0.94 4.91
MBP Intercept 2.67 0.68 0.0029
ln(creatinine) 0.35 0.25 0.1869 1.42 0.82 2.48
ln(MBP) 0.21 0.18 0.2637 0.81 0.55 1.20
Income (low/lower
middle)
0.24 0.81 0.7697 Income: low/low-middle vs. middle/
upper (males)
3.61 1.30 10.03
Gender (males) 0.44 0.41 0.3151 Income: low/low-middle vs. middle-
upper (females)
0.78 0.10 6.15
ln(Lead) 1.00 0.27 0.0046 2.71 1.47 5.00
Income*gender 1.53 0.83 0.0971 Males vs. females (low/low-middle) 7.11 1.12 44.92
Males vs. females (middle/upper) 1.55 0.69 3.46
MBzP Intercept 4.04 0.87 0.0007
ln(creatinine) 0.28 0.24 0.2707 0.76 0.45 1.29
ln(MBzP) 0.39 0.21 0.0912 1.48 0.93 2.36
Child's age 0.05 0.06 0.4167
Income (low/low-
middle)
0.79 0.44 0.1013 2.21 0.83 5.84
Gender (males) 1.07 0.67 0.1390 Males vs. femalesa 2.81 1.45 5.45
ln(lead) 0.84 0.25 0.0066 2.33 1.33 4.06
BMI 0.08 0.04 0.0685 0.92 0.84 1.01
Child's age*gender 0.17 0.06 0.0135 Child's age: males 1.24 1.07 1.44
Child's age: females 1.05 0.94 1.18
MCPP Intercept 3.81 0.46 o0.0001
ln(creatinine) 0.22 0.23 0.3578 1.25 0.75 2.07
ln(MCPP) 0.02 0.14 0.8977 0.98 0.72 1.34
Income (low/low-
middle)
0.90 0.53 0.1187 2.45 0.76 7.84
Gender (males) 1.04 0.38 0.0187 2.83 1.23 6.50
ln(lead) 0.94 0.27 0.0053 2.56 1.41 4.66
MEHHP Intercept 2.66 0.84 0.0090
ln(creatinine) 0.43 0.28 0.1517 1.53 0.83 2.82
ln(MEHHP) 0.34 0.24 0.1771 0.71 0.42 1.20
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Table B1 (continued )






0.89 0.53 0.1180 2.44 0.77 7.78
Gender (males) 1.01 0.37 0.0203 2.74 1.21 6.21
ln(lead) 0.99 0.28 0.0050 2.70 1.45 5.05
MEHP Intercept 3.63 0.53 o0.0001
ln(creatinine) 0.29 0.25 0.2749 1.34 0.77 2.33
ln(MEHP) 0.16 0.14 0.2830 0.85 0.62 1.17
Income (low/low-
Middle)
0.92 0.53 0.1070 2.51 0.79 7.99
Gender (males) 1.03 0.38 0.0210 2.81 1.21 6.56
ln(lead) 0.97 0.28 0.0048 2.64 1.44 4.85
MEOHP Intercept 2.82 0.82 0.0054
ln(creatinine) 0.42 0.29 0.1808 1.52 0.80 2.89
ln(MEOHP) 0.34 0.25 0.1935 0.71 0.41 1.22
Income (low/low-
middle)
0.89 0.53 0.1173 2.44 0.77 7.78
Gender (males) 0.99 0.37 0.0208 2.70 1.20 6.08
ln(lead) 0.99 0.28 0.0051 2.70 1.44 5.05
MEP Intercept 2.70 0.99 0.0193
ln(creatinine) 0.48 0.40 0.2587 1.61 0.67 3.88
ln(MEP) 0.29 0.23 0.2299 0.75 0.45 1.24
Income (low/low-
middle)
0.93 0.52 0.1031 2.52 0.80 7.95
Gender (males) 0.97 0.36 0.0218 2.64 1.19 5.90
ln(lead) 0.96 0.28 0.0059 2.61 1.40 4.86
a Odds ratio calculated at average value of Child's age
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Table B2
Weighted multiple logistic regression estimates from CHMS Cycle 1 with report of a learning disability (6–19 years of age).




BPA Intercept 3.03 0.28 o0.0001
ln(creatinine) 0.10 0.11 0.3623 1.11 0.87 1.41
ln(BPA) 0.09 0.17 0.6089 1.09 0.76 1.57
Smoking at home
(yes)
0.50 0.19 0.0252 1.65 1.08 2.53
Gender (males) 0.57 0.26 0.0467 1.78 1.01 3.12
ln(lead) 1.10 0.36 0.0116
Income (low/lower-
middle)
0.66 0.35 0.0869 Income: low/low-middle vs. mid-
dle/uppera
2.44 1.31 4.52
ln(lead)*Income 1.27 0.45 0.0163 ln(lead): low/low-middle 0.85 0.38 1.86
ln(Lead): middle/upper 3.00 1.47 6.12
Blood
lead
Intercept 3.07 0.26 o0.0001
ln(lead) 1.02 0.35 0.0138
Smoking at home
(yes)
0.57 0.18 0.0088 1.76 1.19 2.61
Income (low/low-
middle)
0.64 0.33 0.0791 Income: low/low-middle vs. mid-
dle/uppera
2.38 1.34 4.24
Gender (males) 0.68 0.29 0.0381 1.98 1.05 3.75
ln(lead) * income 1.23 0.45 0.0195 ln(lead): low/low-middle 0.81 0.37 1.81
ln(lead): middle/upper 2.78 1.40 5.51
MBP Intercept 1.38 0.72 0.0825
ln(creatinine) 0.48 0.14 0.0064 1.61 1.18 2.21
ln(MBP) 0.23 0.16 0.1797 0.79 0.56 1.13
Gender (males) 0.66 0.29 0.0422 1.93 1.03 3.62
Income (low/lower
Middle)
0.78 0.40 0.0790 0.46 0.19 1.11
ln(lead) 0.85 0.28 0.0102 2.35 1.28 4.31
MBzP Intercept 2.96 0.60 0.0005
ln(creatinine) 0.15 0.15 0.3396 1.16 0.84 1.61
ln(MBzP) 0.22 0.16 0.2017 1.24 0.87 1.77
Gender (males) 0.70 0.30 0.0383 2.02 1.05 3.89
Income (low/low-
Middle)
0.70 0.41 0.1184 0.50 0.20 1.23
ln(lead) 0.80 0.28 0.0144 2.23 1.21 4.08
MCPP Intercept 2.42 0.43 0.0002
ln(creatinine) 0.33 0.15 0.0556 1.38 0.99 1.93
ln(MCPP) 0.17 0.16 0.3235
Gender (males) 0.97 0.32 0.0115 Males vs. femalesb 2.08 1.15 3.76
Income (low/low-
Middle)
0.74 0.41 0.0951 0.48 0.19 1.16
ln(lead) 0.83 0.27 0.0111 2.29 1.26 4.17
ln(MCPP) * gender 0.28 0.09 0.0114 ln(MCPP): males 0.89 0.65 1.21
ln(MCPP): females 1.18 0.86 1.62
MEHHP Intercept 1.32 0.97 0.1986
ln(creatinine) 0.48 0.21 0.0415 1.62 1.02 2.55
ln(MEHHP) 0.27 0.25 0.2899 0.76 0.44 1.31
Gender (males) 0.66 0.28 0.0364 1.94 1.05 3.56
Income (low/low-
Middle)
0.72 0.39 0.0947 0.49 0.20 1.16
ln(lead) 0.86 0.27 0.0083 2.37 1.31 4.27
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Table B2 (continued )




MEHP Intercept 2.03 0.38 0.0003
ln(creatinine) 0.39 0.16 0.0344 1.48 1.03 2.11
ln(MEHP) 0.17 0.16 0.3283 0.85 0.59 1.21
Gender (males) 0.68 0.29 0.0366 1.98 1.05 3.71
Income (low/low-
Middle)
0.75 0.40 0.0882 0.47 0.19 1.14
ln(lead) 0.85 0.27 0.0096 2.34 1.29 4.26
MEOHP Intercept 1.45 0.92 0.1421
ln(creatinine) 0.47 0.22 0.0510 1.60 1.00 2.58
ln(MEOHP) 0.27 0.26 0.3197 0.76 0.43 1.35
Gender (males) 0.65 0.28 0.0377 1.92 1.05 3.51
Income (low/low-
Middle)
0.72 0.40 0.0946 0.49 0.20 1.16
ln(lead) 0.86 0.27 0.0085 2.37 1.31 4.28
MEP Intercept 1.29 0.69 0.0874
ln(creatinine) 0.53 0.24 0.0467 1.70 1.01 2.88
ln(MEP) 0.24 0.17 0.1868 0.79 0.54 1.15
Gender (males) 0.63 0.28 0.0451 1.88 1.02 3.49
Income (low/low-
middle)
0.76 0.40 0.0837 0.47 0.19 1.13
ln(lead) 0.84 0.29 0.0142 2.31 1.23 4.34
a Odds ratio calculated at average value of ln(Lead)
b Odds ratio calculated at average value of ln(MCPP)
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Table B3
Weighted multiple logistic regression estimates from CHMS Cycle 1 with reported psychotropic medicine taken in past month
for behavioral problems (6–19 years of age).
Exposure Covariate Estimate SE P-value Odds ratio 95% CI for odds ratio
BPA Intercept 2.53 0.44 0.0001
ln(creatinine) 0.17 0.17 0.3345 0.84 0.58 1.22
ln(BPA) 0.03 0.15 0.8625
Hours slept 0.20 0.07 0.0119 0.82 0.70 0.95
Gender (males) 0.54 0.28 0.0826 Males vs. femalesa 2.16 1.28 3.62
Fasted (yes) 0.69 0.25 0.0195 1.98 1.14 3.45
ln(BPA)*gender 0.65 0.21 0.0093 ln(BPA): males 1.87 1.24 2.83
ln(BPA): females 0.97 0.72 1.31
Blood lead Intercept 2.19 0.47 0.0007
ln(lead) 1.43 0.40 0.0042
Gender (males) 0.73 0.33 0.0485 2.08 1.01 4.29
Fasted (yes) 0.51 0.30 0.1206 Fasted (yes vs. no)b 2.25 1.19 4.26
ln(lead)*fasted 1.62 0.55 0.0135 ln(lead): fasted 0.83 0.34 2.02
ln(lead): no fasting 4.20 1.92 9.17
Hours slept 0.22 0.07 0.0095 0.80 0.68 0.94
MBP Intercept 2.43 0.79 0.0103
ln(creatinine) 0.18 0.26 0.5067 1.19 0.68 2.11
ln(MBP) 0.02 0.22 0.9369 0.98 0.60 1.60
Hours Slept 0.20 0.05 0.0010 0.82 0.74 0.90
Gender (males) 0.92 0.31 0.0138 2.51 1.26 5.01
Fasted (yes) 0.71 0.23 0.0108 2.04 1.22 3.40
MBzP Intercept 1.62 0.63 0.0270
ln(creatinine) 0.05 0.23 0.8306 1.05 0.63 1.76
ln(MBzP) 0.25 0.19 0.2147
Hours slept 0.23 0.06 0.0018 0.80 0.70 0.90
Gender (males) 1.14 0.49 0.0415 Males vs. femalesc 2.45 1.31 4.58
Fasted (yes) 0.77 0.25 0.0110 2.16 1.24 3.77
ln(MBzP)*gender 0.68 0.15 0.0010 ln(MBzP): males 1.54 1.07 2.23
ln(MBzP): females 0.78 0.54 1.13
MCPP Intercept 2.90 0.51 0.0001
ln(creatinine) 0.32 0.29 0.2894
ln(MCPP) 0.51 0.19 0.0202 1.66 1.10 2.51
Hours slept 0.23 0.05 0.0008 0.79 0.71 0.89
Gender (males) 0.93 0.33 0.0181 Males vs. Femalesd 2.42 1.27 4.61
Fasted (yes) 1.34 0.30 0.0010 Fasted (yes vs. no)e 2.45 1.50 3.99
ln(creatinine)*gender 0.59 0.29 0.0640
ln(MCPP)*fasted 0.51 0.15 0.0051 ln(MCPP): fasted 1.00 0.69 1.44
ln(MCPP): no fasting 1.66 1.15 2.40
MEHHP Intercept 2.80 1.05 0.0221
ln(creatinine) 0.28 0.36 0.4473
ln(MEHHP) 0.08 0.30 0.7864 1.09 0.56 2.10
Hours slept 0.20 0.05 0.0014 0.81 0.73 0.91
Gender (males) 0.92 0.32 0.0159 Males vs. femalesd 2.39 1.28 4.46
Fasted (yes) 0.73 0.22 0.0067 2.08 1.28 3.37
ln(creatinine)*gender 0.62 0.29 0.0518
MEHP Intercept 2.55 0.66 0.0027
ln(creatinine) 0.22 0.38 0.5757
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Table B3 (continued )
Exposure Covariate Estimate SE P-value Odds ratio 95% CI for odds ratio
ln(MEHP) 0.01 0.32 0.9795 1.01 0.50 2.05
Hours slept 0.20 0.05 0.0012 0.82 0.74 0.91
Gender (males) 0.91 0.33 0.0184 Males vs. femalesd 2.37 1.26 4.48
Fasted (yes) 0.71 0.23 0.0099 2.03 1.23 3.34
ln(creatinine)*gender 0.61 0.30 0.0671
MEOHP Intercept 2.77 0.92 0.0120
ln(creatinine) 0.29 0.36 0.4405
ln(MEOHP) 0.09 0.30 0.7702 1.09 0.56 2.13
Hours slept 0.21 0.05 0.0014 0.81 0.73 0.91
Gender (males) 0.92 0.32 0.0147 Males vs. femalesd 2.40 1.29 4.46
Fasted (yes) 0.73 0.22 0.0063 2.08 1.29 3.36
ln(creatinine)*gender 0.63 0.28 0.0486
MEP Intercept 3.36 0.82 0.0018
ln(creatinine) 0.35 0.31 0.2853
ln(MEP) 0.16 0.13 0.2471 1.17 0.88 1.54
Hours slept 0.18 0.05 0.0045 0.84 0.75 0.93
Gender (males) 0.96 0.34 0.0168 Males vs. femalesd 2.50 1.30 4.80
Fasted (yes) 0.71 0.23 0.0097 2.03 1.23 3.33
ln(creatinine)*gender 0.61 0.30 0.0664
a Odds ratio calculated at average value of ln(BPA)
b Odds ratio calculated at average value of ln(Lead)
c Odds ratio calculated at average value of ln(MBzP)
d Odds ratio calculated at average value of ln(creatinine)
e Odds ratio calculated at average value of ln(MCPP)
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Table B4
Weighted multiple logistic regression estimates from CHMS Cycle 1 with outcome SDQ Emotional Symptoms (ages 6–17 years).
Exposure Covariate Estimate SE P-value Odds
ratio
95% CI for odds
ratio
BPA Intercept 1.50 1.12 0.2088
ln(creatinine) 0.20 0.13 0.1416 1.23 0.92 1.63
ln(BPA) 0.07 0.05 0.1682 1.07 0.97 1.19
Hours slept 0.27 0.10 0.0183 0.77 0.62 0.95
Gender
(males)
0.41 0.11 0.0032 0.66 0.52 0.84
Fasted (yes) 0.49 0.21 0.0424 1.63 1.02 2.61
Child's age 0.08 0.03 0.0415 0.92 0.86 1.00
Blood lead Intercept 0.22 0.75 0.7758
ln(lead) 0.08 0.21 0.7208 1.08 0.68 1.71
Gender
(males)
0.40 0.18 0.0508 0.67 0.45 1.00
Hours slept 0.19 0.08 0.0370 0.83 0.70 0.99




0.57 0.23 0.0324 1.78 1.06 2.97
MBP Intercept 0.99 0.63 0.1426
ln(creatinine) 0.35 0.17 0.0614 1.42 0.98 2.04
ln(MBP) 0.14 0.16 0.4087 0.87 0.61 1.24
Gender
(males)
0.32 0.16 0.0631 0.72 0.51 1.02
MBzP Intercept 1.92 1.06 0.0962
ln(creatinine) 0.38 0.17 0.0431 1.47 1.01 2.13
ln(MBzP) 0.11 0.08 0.2049 0.90 0.75 1.07
Gender
(males)
0.29 0.15 0.0792 0.75 0.53 1.04
Hours slept 0.24 0.10 0.0386 0.79 0.63 0.99
Child's age 0.08 0.04 0.0503 0.92 0.84 1.00
MCPP Intercept 1.56 1.11 0.1875
ln(creatinine) 0.34 0.18 0.0833 1.41 0.95 2.08
ln(MCPP) 0.06 0.08 0.4643 0.94 0.78 1.13
Gender
(males)
0.29 0.16 0.0890 0.75 0.53 1.05
Hours slept 0.23 0.10 0.0447 0.79 0.63 0.99
Child's age 0.08 0.04 0.0637 0.92 0.85 1.01
MEHHP Intercept 1.69 0.43 0.0023
ln(creatinine) 0.20 0.10 0.0654 1.22 0.98 1.52
ln(MEHHP) 0.05 0.11 0.6388 1.05 0.83 1.33
Gender
(males)
0.30 0.15 0.0764 0.74 0.53 1.04
MEHP Intercept 1.49 0.16 o0.0001
ln(creatinine) 0.25 0.10 0.0336 1.28 1.02 1.60
ln(MEHP) 0.02 0.09 0.8602 0.98 0.80 1.21
Gender
(males)
0.30 0.15 0.0755 0.74 0.53 1.04
MEOHP Intercept 1.68 0.38 0.0011
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Table B4 (continued )
Exposure Covariate Estimate SE P-value Odds
ratio
95% CI for odds
ratio
ln(creatinine) 0.20 0.10 0.0750 1.22 0.98 1.53
ln(MEOHP) 0.06 0.11 0.6145 1.06 0.83 1.34
Gender
(males)
0.30 0.16 0.0796 0.74 0.53 1.04
MEP Intercept 1.56 0.27 0.0001
ln(creatinine) 0.22 0.12 0.0840 1.25 0.96 1.62
ln(MEP) 0.01 0.07 0.8631 1.01 0.87 1.18
Gender
(males)
0.30 0.15 0.0716 0.74 0.53 1.03
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Table B5
Weighted multiple logistic regression estimates from CHMS Cycle 1 with outcome SDQ Hyperactivity/Inattention (ages 6–17
years).




BPA Intercept 1.96 0.14 o0.0001
ln(creatinine) 0.08 0.12 0.5184 0.92 0.71 1.20
ln(BPA) 0.27 0.05 0.0003
Smoking at home (yes) 0.91 0.24 0.0031 Smoking at home (yes vs.
no)a
1.96 1.23 3.11
ln(lead) 0.94 0.16 0.0001 2.56 1.79 3.65
ln(BPA)*smoking at home 0.67 0.21 0.0079 ln(BPA): smoking at home 0.67 0.46 1.00
ln(BPA): no smoking at home 1.31 1.18 1.46
Blood
lead
Intercept 2.06 0.20 o0.0001
ln(lead) 0.85 0.18 0.0005 2.33 1.59 3.43
Gender (males) 0.36 0.18 0.0705 1.44 0.96 2.14
Smoking at home (Yes) 0.74 0.36 0.0620 2.10 0.96 4.62
MBP Intercept 2.40 0.73 0.0070 0.09 0.02 0.45
ln(creatinine) 0.05 0.20 0.7879 1.06 0.69 1.62
ln(MBP) 0.16 0.21 0.4626 Smoking at home (yes vs.
no)b
1.59 0.94 2.71
ln(lead) 0.96 0.20 0.0006 2.61 1.67 4.07
Smoking at home (yes) 2.48 0.92 0.0204
ln(MBP)*smoking at
home
0.58 0.28 0.0628 ln(MBP): smoking at home 0.66 0.39 1.12
ln(MBP): no smoking at
home
1.17 0.78 1.76
MBzP Intercept 2.25 0.30 o0.0001
ln(creatinine) 0.02 0.11 0.8288 0.98 0.77 1.23
ln(MBzP) 0.16 0.09 0.1047 1.17 0.96 1.43
ln(lead) 0.97 0.19 0.0003 2.63 1.74 3.99
MCPP Intercept 1.97 0.22 o0.0001
ln(creatinine) 0.05 0.13 0.7145 0.95 0.71 1.27
ln(MCPP) 0.20 0.10 0.0821 1.22 0.97 1.53
ln(lead) 0.95 0.20 0.0006 2.58 1.67 4.00
MEHHP Intercept 1.89 0.32 0.0001
ln(creatinine) 0.07 0.12 0.6030 1.07 0.81 1.40
ln(MEHHP) 0.04 0.08 0.5976 1.04 0.88 1.23
ln(lead) 0.98 0.20 0.0004 2.68 1.74 4.12
MEHP Intercept 1.68 0.17 o0.0001
ln(creatinine) 0.12 0.12 0.3375 1.13 0.86 1.49
ln(MEHP) 0.05 0.11 0.6440 0.95 0.75 1.20
ln(lead) 0.99 0.20 0.0004 2.70 1.73 4.20
MEOHP Intercept 1.79 0.31 0.0001
ln(creatinine) 0.08 0.12 0.5150 1.09 0.83 1.43
ln(MEOHP) 0.02 0.08 0.8472 1.02 0.85 1.21
ln(lead) 0.99 0.20 0.0004 2.68 1.73 4.15
MEP Intercept 1.50 0.33 0.0008
ln(creatinine) 0.15 0.12 0.2101 1.17 0.90 1.51
ln(MEP) 0.07 0.06 0.3207 0.94 0.82 1.08
ln(lead) 0.99 0.20 0.0005 2.69 1.72 4.20
a Odds ratio calculated at average value of ln(BPA)
b Odds ratio calculated at average value of ln(MBP)
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Table B6
Weighted multiple logistic regression estimates from CHMS Cycle 1 with outcome SDQ Total Difﬁculties (ages 6–17 years).
Exposure Covariate Estimate SE P-value Odds
ratio
95% CI for odds
ratio
BPA Intercept 2.36 0.18 o0.0001
ln(creatinine) 0.18 0.15 0.2686 0.84 0.60 1.17
ln(BPA) 0.13 0.08 0.1118 1.14 0.96 1.36
Smoking at
home (yes)
0.57 0.28 0.0680 1.76 0.95 3.27
ln(lead) 0.81 0.25 0.0080 2.24 1.29 3.87
Blood lead Intercept 2.25 0.16 o0.0001
ln(lead) 0.77 0.22 0.0049 2.16 1.33 3.51
Smoking at
home (yes)
0.74 0.38 0.0739 2.10 0.92 4.81
MBP Intercept 2.45 0.95 0.0250
ln(creatinine) 0.04 0.26 0.8961 0.97 0.54 1.72
ln(MBP) 0.09 0.25 0.7353 1.09 0.62 1.91
ln(lead) 0.84 0.22 0.0029 2.32 1.43 3.76
MBzP Intercept 3.15 0.39 o0.0001
ln(creatinine) 0.20 0.19 0.3213 0.82 0.54 1.25
ln(MBzP) 0.31 0.11 0.0189 1.37 1.06 1.76
ln(lead) 0.82 0.24 0.0056 2.26 1.34 3.82
MCPP Intercept 2.19 0.29 o0.0001
ln(creatinine) 0.02 0.25 0.9427 0.98 0.57 1.69
ln(MCPP) 0.06 0.20 0.7691 1.06 0.68 1.66
ln(lead) 0.85 0.23 0.0034 2.33 1.41 3.84
MEHHP Intercept 1.72 0.77 0.0457
ln(creatinine) 0.11 0.28 0.7079 1.11 0.60 2.05
ln(MEHHP) 0.11 0.18 0.5451 0.89 0.60 1.33
ln(lead) 0.87 0.25 0.0051 2.38 1.38 4.10
MEHP Intercept 1.92 0.31 0.0001
ln(creatinine) 0.12 0.24 0.6314 1.13 0.66 1.93
ln(MEHP) 0.16 0.18 0.3910 0.86 0.58 1.26
ln(lead) 0.88 0.24 0.0035 2.41 1.43 4.07
MEOHP Intercept 1.69 0.70 0.0347
ln(creatinine) 0.12 0.28 0.6654 1.13 0.61 2.10
ln(MEOHP) 0.14 0.19 0.4678 0.87 0.57 1.32
ln(lead) 0.87 0.25 0.0049 2.39 1.38 4.12
MEP Intercept 2.25 0.48 0.0007
ln(creatinine) 0.00 0.20 0.9975 1.00 0.64 1.55
ln(MEP) 0.03 0.10 0.7580 1.03 0.83 1.29
ln(lead) 0.86 0.25 0.0061 2.36 1.35 4.11
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Table C1
Summary of Multiple Logistic Regression Results for Parent or Self-Reported Outcomes from the Canadian Health Measures
Survey Cycle 1 (Weighted) for All Children.
ADD/ADHD Learning disability Medicine taken
Contaminant Ages 6–19 yrs OR (95%
CI)
Contaminant Ages 6–19 yrs OR (95%
CI)
Contaminant Ages 6–19 yrs OR (95%
CI)
BPA 1.29 (0.86–1.94) BPA 1.09 (0.76–1.57) BPA M: 1.87 (1.24–2.83)
F: 0.97 (0.72–1.31)a
MBP 0.81 (0.55–1.20) MBP 0.79 (0.56–1.13) MBP 0.98 (0.60-1.60)
MBzP 1.48 (0.93–2.36) MBzP 1.24 (0.87–1.77) MBzP M: 1.54 (1.07–2.23)
F: 0.78 (0.54–1.13)a
MCPP 0.98 (0.72–1.34) MCPP M: 0.89 (0.65–1.21) MCPP FS: 1.00 (0.69-1.44)
F: 1.18 (0.86–1.62)a NFS: 1.66 (1.15-2.40)a
MEHHP 0.71 (0.42.1.20) MEHHP 0.76 (0.44–1.31) MEHHP 1.09 (0.56–2.10)
MEHP 0.85 (0.62–1.17) MEHP 0.85 (0.59–1.21) MEHP 1.01 (0.50–2.05)
MEOHP 0.71 (0.41–1.22) MEOHP 0.76 (0.43–1.35) MEOHP 1.09 (0.56–2.13)
MEP 0.75 (0.45–1.24) MEP 0.79 (0.54–1.15) MEP 1.17 (0.88–1.54)
Blood lead 2.39 (1.32–4.32) Blood lead LI: 0.81 (0.37–1.81) Blood lead FS: 0.83 (0.34–2.02)
HI: 2.78 (1.40–5.51)a NFS: 4.20 (1.92–9.17)a
a Interaction terms signiﬁcant at 5% level between contaminant and other covariates. M: males; F: females; LI: low income;
HI; higher income; FS: fasting sample; NFS: non-fasting sample; Models adjusted for covariates as determined by a stepwise
multiple regression procedure.
Table C2
Summary of multiple regression results for SDQ outcomes from the Canadian health measures survey cycle 1 (weighted) for all
children 6–17 years.
SDQ: Total difﬁculties SDQ: Emotional symptoms SDQ: Hyperactivity/inattention
Contaminant Ages 6–17 yrs OR (95%
CI)
Contaminant Ages 6–17 yrs OR (95%
CI)
Contaminant Ages 6–17 yrs OR (95%
CI)
BPA 1.14 (0.96–1.36) BPA 1.07 (0.97–1.19) BPA ETS: 0.67 (0.46–1.00)
NETS: 1.31 (1.18-1.46)a
MBP 1.09 (0.62–1.91) MBP 0.87 (0.61–1.24) MBP 1.59 (0.94–2.71)
MBzP 1.37 (1.06–1.76) MBzP 0.90 (0.75–1.07) MBzP 1.17 (0.96–1.43)
MCPP 1.06 (0.68–1.66) MCPP 0.94 (0.78–1.13) MCPP 1.22 (0.97–1.53)
MEHHP 0.89 (0.60–1.33) MEHHP 1.05 (0.83–1.33) MEHHP 1.04 (0.88–1.23)
MEHP 0.86 (0.58–1.26) MEHP 0.98 (0.80–1.21) MEHP 0.95 (0.75–1.20)
MEOHP 0.87 (0.57–1.32) MEOHP 1.06 (0.83–1.34) MEOHP 1.02 (0.85–1.21)
MEP 1.03 (0.83–1.29) MEP 1.01 (0.87–1.18) MEP 0.94 (0.82–1.08)
Blood lead 2.16 (1.33–3.51) Blood lead 1.08 (0.68–1.71) Blood lead 2.33 (1.59–3.43)
a Interaction terms signiﬁcant at 5% level between contaminant and other covariates. ETS: smoking in home; NETS: no
smoking in home; Models adjusted for covariates as determined by a stepwise multiple regression procedure.
T.E. Arbuckle et al. / Data in Brief 8 (2016) 784–802 801Transparency document. Supplementary material
Transparency data associated with this article can be found in the online version at
http://dx.doi.org/10.1016/j.dib.2016.06.017.
T.E. Arbuckle et al. / Data in Brief 8 (2016) 784–802802References
[1] T.E. Arbuckle, K. Davis, K. Boylan, M. Fisher, Fu. J. BPA, phthalates and lead and learning and behavioral problems in
Canadian children 6–11 years of age: CHMS 2007–2009, Neurotoxicology 54 (2016) 89–98. http://dx.doi.org/10.1016/j.
neuro.2016.03.014.
[2] Health Canada. Report on Human Biomonitoring of Environmental Chemicals in Canada, Results of the Canadian Health
Measures Survey Cycle 1 (2007–2009), August 2010, 〈http://www.hc-sc.gc.ca/ewh-semt/contaminants/human-humaine/
index-eng.php〉.
[3] Statistics Canada, Canadian Health Measures Survey (CHMS): Data User Guide Cycle 1. 〈http://www23.statcan.gc.ca/imdb-
bmdi/document/5071_D2_T1_V1-eng.htm〉, 2011 (accessed 20.05.2015).
[4] D.B. Barr, L.C. Wilder, S.P. Caudill, A.J. Gonzalez, L.L. Needham, J.L. Pirkle, Urinary creatinine concentrations in the U.S.
populations: implications for urinary biologic monitoring measurements, Environ. Health Perspect. 113 (2005) 192–200.
